DRUG/DEVICE

Treprostinil Inhalation Solution

ROUTE OF ADMINISTRATION

Inhaled

THERAPEUTIC PLATFORM

Tyvaso®

CLINICAL TRIAL

TERRITORY

Worldwide

COMMERCIAL PRODUCT

www.tyvaso.com

STATUS

Phase 3

Tyvaso® for PH-COPD is investigational and not FDA approved.